Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Accounts Payables (2020 - 2025)

Historic Accounts Payables for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $3.4 million.

  • RxSight's Accounts Payables fell 2628.25% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 2628.25%. This contributed to the annual value of $4.5 million for FY2024, which is 1762.88% up from last year.
  • RxSight's Accounts Payables amounted to $3.4 million in Q3 2025, which was down 2628.25% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, RxSight's Accounts Payables peaked at $7.1 million during Q1 2025, and registered a low of $1.7 million during Q4 2021.
  • Moreover, its 5-year median value for Accounts Payables was $3.8 million (2023), whereas its average is $3.7 million.
  • Per our database at Business Quant, RxSight's Accounts Payables soared by 14671.79% in 2022 and then crashed by 3428.85% in 2025.
  • Quarter analysis of 5 years shows RxSight's Accounts Payables stood at $1.7 million in 2021, then surged by 53.64% to $2.6 million in 2022, then skyrocketed by 48.86% to $3.9 million in 2023, then grew by 17.63% to $4.5 million in 2024, then fell by 25.68% to $3.4 million in 2025.
  • Its Accounts Payables stands at $3.4 million for Q3 2025, versus $3.3 million for Q2 2025 and $7.1 million for Q1 2025.